1. Home
  2. AUID vs CTMX Comparison

AUID vs CTMX Comparison

Compare AUID & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUID
  • CTMX
  • Stock Information
  • Founded
  • AUID 2009
  • CTMX 2008
  • Country
  • AUID United States
  • CTMX United States
  • Employees
  • AUID N/A
  • CTMX N/A
  • Industry
  • AUID Computer Software: Prepackaged Software
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUID Technology
  • CTMX Health Care
  • Exchange
  • AUID Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • AUID 88.5M
  • CTMX 89.1M
  • IPO Year
  • AUID N/A
  • CTMX 2015
  • Fundamental
  • Price
  • AUID $6.74
  • CTMX $0.87
  • Analyst Decision
  • AUID
  • CTMX Buy
  • Analyst Count
  • AUID 0
  • CTMX 6
  • Target Price
  • AUID N/A
  • CTMX $5.77
  • AVG Volume (30 Days)
  • AUID 30.0K
  • CTMX 1.2M
  • Earning Date
  • AUID 11-07-2024
  • CTMX 11-07-2024
  • Dividend Yield
  • AUID N/A
  • CTMX N/A
  • EPS Growth
  • AUID N/A
  • CTMX N/A
  • EPS
  • AUID N/A
  • CTMX 0.16
  • Revenue
  • AUID $758,638.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • AUID N/A
  • CTMX $11.79
  • Revenue Next Year
  • AUID N/A
  • CTMX N/A
  • P/E Ratio
  • AUID N/A
  • CTMX $5.35
  • Revenue Growth
  • AUID 97.40
  • CTMX 33.66
  • 52 Week Low
  • AUID $5.36
  • CTMX $0.83
  • 52 Week High
  • AUID $13.63
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • AUID 43.81
  • CTMX 31.75
  • Support Level
  • AUID $6.65
  • CTMX $0.83
  • Resistance Level
  • AUID $7.00
  • CTMX $1.08
  • Average True Range (ATR)
  • AUID 0.53
  • CTMX 0.07
  • MACD
  • AUID -0.11
  • CTMX -0.01
  • Stochastic Oscillator
  • AUID 14.14
  • CTMX 10.24

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: